CYBERONICS, INC.

Manufacturer adverse-event records for CYBERONICS, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 1996–2023 · heavy-book · elevated Death-code · balanced

Death-code intensity

CYBERONICS, INC. carries an elevated Death-code share

Death-coded event_type rows are 1,839 of 29,110 (6.32% · elevated tercile among 434 manufacturers). Absolute volume is heavy-book.

What the Death-code reading shows for CYBERONICS, INC.

The standout signal for CYBERONICS, INC. is Death-code intensity: 6.32% of 29,110 reports (elevated tercile), while absolute volume is heavy-book.

As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair CYBERONICS, INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.

Reports span 9 device types, led in this extract by Malfunction at 17,416 (59.8% of event_type total). Peak single-year volume reaches 2,920 reports across 24 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

29,110
Total Reports
1,839
Event-type Death
9,745
Injury Reports
9
Device Types

Event Types

Malfunction 17,416 (59.8%)
Injury 9,745 (33.5%)
Death 1,839 (6.3%)
Other 78 (0.3%)
32 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

16,293 (51.4%)
Required Intervention 5,552 (17.5%)
Other 2,116 (6.7%)
Hospitalization 2,066 (6.5%)
R 1,968 (6.2%)
Death 1,793 (5.7%)
Life Threatening 967 (3.0%)
Disability 315 (1.0%)
L 293 (0.9%)
O 175 (0.6%)
S 146 (0.5%)
H 23 (0.1%)
D 4 (0.0%)
Congenital Anomaly 3 (0.0%)

Yearly Trend

96
1996: 1
98
1998: 4
99
1999: 14
00
2000: 26
01
2001: 661
02
2002: 568
03
2003: 894
04
2004: 1,094
05
2005: 911
06
2006: 439
07
2007: 2,158
08
2008: 2,920
09
2009: 2,498
10
2010: 2,561
11
2011: 2,448
12
2012: 2,193
13
2013: 2,081
14
2014: 2,185
15
2015: 2,218
16
2016: 1,809
17
2017: 1,138
18
2018: 286
20
2020: 1
23
2023: 2